Clinuvel Pharmaceuticals Ltd (FRA:UR9)
€ 9.02 -0.08 (-0.88%) Market Cap: 456.07 Mil Enterprise Value: 344.82 Mil PE Ratio: 22.34 PB Ratio: 3.85 GF Score: 91/100

Clinuvel Pharmaceuticals Ltd Corporate Presentation Transcript

Oct 25, 2021 / 06:00AM GMT
Release Date Price: €25.1 (-0.75%)
Malcolm Bull
CLINUVEL Pharmaceuticals Ltd - Head of IR

Presentation
Oct 25, 2021 / 06:00AM GMT

=====================
Corporate Participants
=====================
* Malcolm Bull
CLINUVEL Pharmaceuticals Ltd - Head of IR
* Philippe Wolgen
CLINUVEL Pharmaceuticals Ltd - MD

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot